TEMPLATE: CLINICAL STUDY PROTOCOL

For each pre-clinical toxicity study, a statement as to whether or not the study was conducted in full compliance with the FDA’s Good Laboratory Practice (GLP) standards (21 CFR Part 58). If a study was conducted in compliance with GLP standards, specify if the respective study report included as part of the Integrated Summary has been ... ................
................